SHANXI INSTALL (02520) released its 2025 annual performance with a net profit attributable to shareholders of 138 million yuan, a year-on-year decrease of 9.9%.
Shanxi Installation (02520) released its annual performance for the year ending December 31, 2025, with operating income of 10.531 billion yuan, a year-on-year decrease of 14%; net profit attributable to shareholders of the parent company was 1.38 billion yuan, a year-on-year decrease of 9.9%; basic earnings per share were 0.10 yuan, and a proposed final dividend of 0.20380 yuan (tax included) for every 10 shares.
SHANXI INSTALL (02520) has announced its annual performance for the year ending December 31, 2025, with operating income of 10.531 billion yuan, a decrease of 14% year-on-year; net profit attributable to shareholders of the parent company was 138 million yuan, a decrease of 9.9% year-on-year; basic earnings per share was 0.10 yuan, with a proposed final dividend of 0.20380 yuan per 10 shares (tax included).
The decrease in operating income during the period was mainly due to a decrease in revenue from specialized supporting projects and other projects.
Related Articles
Red Star Macalline Group Corporation (01528) released its annual performance, with a net loss attributable to shareholders of 24.094 billion yuan, an increase of 208.05% year-on-year.
SAIMO (02571) released its annual performance, with its shareholders' net profit amounting to 56.265 million RMB, representing a year-on-year increase of 4.84%.
CANBRIDGE-B (01228) announced its annual performance, with a net profit of 1481.8 million yuan, turning losses into profits year-on-year.
Red Star Macalline Group Corporation (01528) released its annual performance, with a net loss attributable to shareholders of 24.094 billion yuan, an increase of 208.05% year-on-year.
SAIMO (02571) released its annual performance, with its shareholders' net profit amounting to 56.265 million RMB, representing a year-on-year increase of 4.84%.
CANBRIDGE-B (01228) announced its annual performance, with a net profit of 1481.8 million yuan, turning losses into profits year-on-year.
RECOMMEND
Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026
Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026
Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026
